Adalimumab Induces Deep Remission in Patients With Crohn's Disease-Reference-Cited by-同舟云学术

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

Published:2014-03 Issue:3 Volume:12 Page:414-422.e5
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Colombel Jean–Frédéric,Rutgeerts Paul J.,Sandborn William J.,Yang Mei,Camez Anne,Pollack Paul F.,Thakkar Roopal B.,Robinson Anne M.,Chen Naijun,Mulani Parvez M.,Chao Jingdong

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Management of Crohn’s disease in adults;Hanauer;Am J Gastroenterol,2001

2. Long-term evolution of disease behavior of Crohn’s disease;Cosnes;Inflamm Bowel Dis,2002

3. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease;Louis;Gut,2001

4. Endoscopic monitoring of Crohn’s disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives;Landi;Gastroenterology,1992

5. Clinical, biological, and endoscopic picture of attacks of Crohn’s disease. Evolution on prednisolone. Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives;Modigliani;Gastroenterology,1990

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Adalimumab Therapy for Ankylosing Spondylitis;Current Rheumatology Reviews;2024-12

2. The degree of bowel remission predicts phenotype progression in Crohn's disease;United European Gastroenterology Journal;2024-05-16

3. A Crohn-betegég terápiás stratégiája;Orvosi Hetilap;2024-03-12

4. Optimal Management of Refractory Crohn’s Disease: Current Landscape and Future Direction;Clinical and Experimental Gastroenterology;2024-03

5. Treat to target in Crohn’s disease: A practical guide for clinicians;World Journal of Gastroenterology;2024-01-07